| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From Department of Internal Medicine II-Cardiology (W.K., N.K.), University of Ulm Medical Center, Ulm, Germany; GSF National Research Centre for Environment and Health (J.B., B.T., H.L., C.M., A.S.), Institute of Epidemiology, Neuherberg, Germany; University of North Carolina at Chapel Hill (L.C.), Chapel Hill, NC; German Diabetes Clinic (S.M., H.K., C.H.), German Diabetes Centre, Leibniz Centre at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Correspondence to Dr Barbara Thorand, MPH; GSF National Research Center for Environment and Health, Institute of Epidemiology, Postfach 1129, 85758 Neuherberg, Germany. E-mail thorand{at}gsf.de
Objectives We performed a prospective casecohort study in initially healthy, middle-aged men and women from the MONICA/KORA Augsburg studies conducted between 1984 and 2002 to assess the role of IL-18 in comparison with IL-6 and CRP in the prediction of incident coronary heart disease (CHD).
Methods and Results Concentrations of IL-18 were measured in 382 case subjects with incident CHD and 1980 noncases. Mean follow-up was 11 years. Baseline concentrations of IL-18 were slightly higher in cases than in noncases (172.4 [1.0] versus 161.3 [1.0] pg/mL, respectively; P=0.114), but were clearly elevated for C-reactive protein (CRP) and IL-6 in cases compared with noncases. In multivariable analyses, accounting for classical cardiovascular risk factors and inflammatory markers, no statistically significant association was seen between increased concentrations of IL-18 and incident CHD both in men (hazard ratio [HR] and 95% confidence intervals [CIs] comparing extreme tertiles, 1.20; 95% CI, 0.85 to 1.69), and in women (HR, 1.25; 95% CI, 0.67 to 2.34). However, in this population increased concentrations of CRP and IL-6 were found to be independent predictors of future CHD events, even after multivariable adjustment.
Conclusions Elevated concentrations of CRP and IL-6, but not IL-18, were independently associated with risk of CHD in subjects from an area with moderate absolute risk.
Within the MONICA/KORA Augsburg casecohort study, concentrations of IL-18 were measured in 382 cases with incident coronary heart disease (CHD) and 1980 noncases. We found no statistically significant association between increased IL-18 concentrations and incident CHD, whereas CRP and IL-6 were independent predictors of future cardiovascular risk in this population.
Key Words: casecohort study coronary heart disease IL-18 inflammation risk factors
This article has been cited by other articles:
![]() |
D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 483 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 496 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Elliott, J. C. Chambers, W. Zhang, R. Clarke, J. C. Hopewell, J. F. Peden, J. Erdmann, P. Braund, J. C. Engert, D. Bennett, et al. Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease JAMA, July 1, 2009; 302(1): 37 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
Wenwei Liu, Qizhu Tang, Hua Jiang, Xiangwu Ding, Yongsheng Liu, Rui Zhu, Yongqian Tang, Bin Li, and Min Wei Promoter Polymorphism of Interleukin-18 in Angiographically Proven Coronary Artery Disease Angiology, April 1, 2009; 60(2): 180 - 185. [Abstract] [PDF] |
||||
![]() |
M. Troseid, I. Seljeflot, E. M. Hjerkinn, and H. Arnesen Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia Diabetes Care, March 1, 2009; 32(3): 486 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Stott, P. Welsh, A. Rumley, M. Robertson, I. Ford, N. Sattar, R. G J Westendorp, J W. Jukema, S. M Cobbe, and G. D O Lowe Adipocytokines and risk of stroke in older people: a nested case-control study Int. J. Epidemiol., February 1, 2009; 38(1): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B Schnabel and S. Blankenberg Commentary: Circulating cytokines and risk stratification of stroke incidence--will we do better in future? Int. J. Epidemiol., February 1, 2009; 38(1): 261 - 262. [Full Text] [PDF] |
||||
![]() |
A. D. Hingorani, T. Shah, J. P. Casas, S. E. Humphries, and P. J. Talmud C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clin. Chem., February 1, 2009; 55(2): 239 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wong, M. Freiberg, R. Tracy, and L. Kuller Epidemiology of Cytokines: The Women On the Move through Activity and Nutrition (WOMAN) Study Am. J. Epidemiol., August 15, 2008; 168(4): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Welsh, G. D.O. Lowe, J. Chalmers, D. J. Campbell, A. Rumley, B. C. Neal, S. W. MacMahon, and M. Woodward Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke Stroke, August 1, 2008; 39(8): 2226 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, V. Witzel, G. Baumann, and K. Stangl Current diagnostic concepts to detect coronary artery disease in women Eur. Heart J., March 2, 2008; 29(6): 707 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Addabbo, F. Mallamaci, D. Leonardis, R. Tripepi, G. Tripepi, M. S. Goligorsky, and C. Zoccali Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3521 - 3526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thompson, D. Novick, C. J. Stock, J. Sanders, D. Brull, J. Cooper, P. Woo, G. Miller, M. Rubinstein, and S. E. Humphries Free Interleukin (IL)-18 Levels, and the Impact of IL18 and IL18BP Genetic Variation, in CHD Patients and Healthy Men Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2743 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Thompson, P. A. McCaskie, J. P. Beilby, J. Hung, M. Jennens, C. Chapman, P. Thompson, and S. E. Humphries IL18 Haplotypes Are Associated with Serum IL-18 Concentrations in a Population-Based Study and a Cohort of Individuals with Premature Coronary Heart Disease Clin. Chem., December 1, 2007; 53(12): 2078 - 2085. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |